Načítá se...
Translating Genomic Insights into Cardiovascular Medicines: Opportunities and Challenges of CRISPR-Cas9
The growing appreciation of human genetics and genomics in cardiovascular disease (CVD) accompanied by the technological breakthroughs in genome editing, particularly the CRISPR-Cas9 technologies, has presented an unprecedented opportunity to explore the application of genome editing tools in cardio...
Uloženo v:
| Vydáno v: | Trends Cardiovasc Med |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7765739/ https://ncbi.nlm.nih.gov/pubmed/32603681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tcm.2020.06.008 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|